ArticlePoultry science2026
Fermentation alleviates the adverse effect of peony seed meal on hepatocytes.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peony seed meal (PSM), a protein-rich byproduct of peony seed oil extraction, holds promise as an alternative protein source for animal feed. However, our previous research found that when PSM is used as a protein component in chicken feed without pre-treatment, it caused damage to the chicken body, especially to the liver, which is the main detoxification organ. In the present study, the effect of alcohol extract of PSM (aPSM) on hepatocytes was investigated, and the fermentation method was used to attempt to reduce the adverse effect of PSM. The results of in vitro cultured chicken primary hepatocytes showed that, aPSM (> 10 mg/mL) reduced cell viability and intracellular aspartate aminotransferase (AST) and alanine aminotransferase (ALT), increased extracellular AST and ALT, and also changed the antioxidant indexes superoxide dismutase (SOD) and catalase (CAT) (P < 0.05). All above adverse effects were significantly attenuated when PSM was fermented with Aspergillus Niger and Aspergillus oryzae (P < 0.05). In addition, 795 metabolites of aPSM were detected using plant wide targeted metabonomics (PWTM). By comparing the metabolite profiles before and after fermentation, the types and abundances of bioactive substances in aPSM changed substantially. By screening 551 differential metabolites, Lyso PC was found to adversely affect the hepatocytes viability (P < 0.05), and their contents decreased after fermentation. The above results indicate that the adverse effect of PSM on hepatocytes can be reduced by fermentation, and Lyso PC maybe the potential causal substance. This study analyzed the metabonomics of PSM for the first time using PWTM, providing a theoretical basis for the safe utilization of PSM as a dietary protein source.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.